Overview
Acute Myelogenous Leukemia is a timely compilation of new concepts in the molecular pathogenesis and molecular therapy of acute myelogenous leukemia (AML). The focus is on selected critical molecular determinants of AML pathogenesis and pathophysiology and the exploitation of these factors by diverse therapeutic agents and modalities. Bringing together new concepts and findings in the basic and clinical science of AML, the book emphasizes the molecular basis for new therapies that stand to have the greatest potential impact on the clinical face of these diseases. The text provides insights into selected novel strategies currently and prospectively being developed, including interruption of specific signal transduction pathways, modulation of gene expression, attempts to reinstate differentiation, and immunomodulation. There is an emphasis throughout on the bidirectional flow of knowledge between the clinical and laboratory arenas, and both basic and clinical scientists will benefit from this translational text.
Full Product Details
Author: Judith E. Karp
Publisher: Humana Press Inc.
Imprint: Humana Press Inc.
Edition: Softcover reprint of hardcover 1st ed. 2007
Dimensions:
Width: 17.80cm
, Height: 2.30cm
, Length: 25.40cm
Weight: 0.854kg
ISBN: 9781617376757
ISBN 10: 1617376752
Pages: 426
Publication Date: 09 November 2010
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
"From the reviews: ""...warmly recommend this book as a comprehensive, up-to-date, and detailed yet concise source of information about AML."" -The New England Journal of Medicine ""Acute Myelogenous Leukemia, edited by Judith E. Karp, MD, of Johns Hopkins University, is a multiauthored textbook directed towards the hematologist managing acute leukemia ! . It focuses on new approaches, both practical and theoretical, based on laboratory data as well as clinical studies. ! This textbook includes up-to-date, well-referenced chapters ! . It is a welcomed edition to provide specific information and reference data for hematologists who specialize in AML management."" (Barry Cooper, Baylor University Medical Center Proceedings, Vol. 21 (1), 2008) ""The book begins with an overview of the disease and ends with a chapter on some of the particular challenges faced by clinicians ! . For clinicians involved in investigation of new agents, there is considerable usefulness ! . In Acute Myelogenous Leukemia, the reader will find reviews of some of the newer agents and treatment strategies for this uncommon but devastating disease. In addition, this is a reliable source for thorough and clearly written explanations of the scientific development of these new agents."" (Laura C. Michaelis, Journal of the American Medical Association, November, 2007)"
From the reviews: ...warmly recommend this book as a comprehensive, up-to-date, and detailed yet concise source of information about AML. -The New England Journal of Medicine Acute Myelogenous Leukemia, edited by Judith E. Karp, MD, of Johns Hopkins University, is a multiauthored textbook directed towards the hematologist managing acute leukemia ! . It focuses on new approaches, both practical and theoretical, based on laboratory data as well as clinical studies. ! This textbook includes up-to-date, well-referenced chapters ! . It is a welcomed edition to provide specific information and reference data for hematologists who specialize in AML management. (Barry Cooper, Baylor University Medical Center Proceedings, Vol. 21 (1), 2008) The book begins with an overview of the disease and ends with a chapter on some of the particular challenges faced by clinicians ! . For clinicians involved in investigation of new agents, there is considerable usefulness ! . In Acute Myelogenous Leukemia, the reader will find reviews of some of the newer agents and treatment strategies for this uncommon but devastating disease. In addition, this is a reliable source for thorough and clearly written explanations of the scientific development of these new agents. (Laura C. Michaelis, Journal of the American Medical Association, November, 2007)
